
Excitotoxicity in Neurological Diseases
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
It can be reasonably anticipated that, over the next generations, the proportion of elderly people will remarkably increase and, with this, the number ofpersons suffering from acute (e.g. cerebral ischemia) or chronic neurodegenerative disorders. To date, approved drugs only alleviate the symptoms ofthese diseases (for instance, acetylcholinesterase inhibitors in Alzheimer disease and L-dopa and dopamine-agonists in Parkinson disease), while none seems to stop the progression of the degenerative processes underlying them. The development of effective preventive or protective therapies has been impeded by the limitations of our knowledge of the causes and the mechanisms by which neurons die in neurodegenerative disorders. Evidence accumulated in the past 20 years indicated that the major excitatory neurotransmitter glutamate may play a role as neurotoxin in several conditions. In particular, the glutamatergic system dysfunction seems to be an early event working as a common pathway in the pathogenesis ofa large number ofacute and chronic neurological disorders, in strict conjunction with other important mechanisms, such as oxidative stress and energetic failure, and probably triggered by different mechanisms in various diseases. In consideration of that, drug discovery efforts over the last decade have been focused on the search for drugs that either reduce glutamate synaptic levels or block its postsynaptic effects. Despite numerous reviews on basic mechanisms and clinical aspects ofthe excitotoxic phenomenon, so far no comprehensive book has covered the topic in all its complexity, starting from basic pharmacological mechanisms, to .animal models of diseases and finally to clinical pathogenic and therapeutic implications.
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
- Gebunden
- 375 Seiten
- Erschienen 2011
- Wiley-VCH
- paperback
- 424 Seiten
- Erschienen 2010
- Thieme
- Kartoniert
- 212 Seiten
- Erschienen 2022
- medhochzwei
- paperback -
- Erschienen 2005
- Steinkopf
- hardcover
- 994 Seiten
- Erschienen 2009
- Wiley-VCH
- Hardcover
- 1096 Seiten
- Erschienen 2016
- Wiley-Blackwell
- paperback
- 266 Seiten
- Erschienen 2020
- Academic Press
- Hardcover
- 191 Seiten
- Erschienen 2013
- ROYAL SOCIETY OF CHEMISTRY
- Hardcover
- 540 Seiten
- Erschienen 1996
- John Wiley & Sons Inc